Bacteriophage (phage) is the general name of viruses that infect bacteria, fungi, algae, actinomycetes or spirochetes and other microorganisms. It is called bacteriophage because it can partially cause the lysis of host bacteria, and can be widely used in various fields of human life.
The global Ds DNA Bacteriophage market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ds DNA Bacteriophage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ds DNA Bacteriophage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ds DNA Bacteriophage in Agriculture is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ds DNA Bacteriophage include Thermo Fisher, Agilent, NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations and Locus Biosciences, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ds DNA Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ds DNA Bacteriophage.
Report Scope
The Ds DNA Bacteriophage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ds DNA Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ds DNA Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Agilent
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
Tail Structure Bacteriophage
Tailless Structure Bacteriophage
Segment by Application
Agriculture
Food lndustry
Human Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ds DNA Bacteriophage companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ds DNA Bacteriophage Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tail Structure Bacteriophage
1.2.3 Tailless Structure Bacteriophage
1.3 Market by Application
1.3.1 Global Ds DNA Bacteriophage Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Agriculture
1.3.3 Food lndustry
1.3.4 Human Health
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ds DNA Bacteriophage Market Perspective (2019-2030)
2.2 Ds DNA Bacteriophage Growth Trends by Region
2.2.1 Global Ds DNA Bacteriophage Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ds DNA Bacteriophage Historic Market Size by Region (2019-2024)
2.2.3 Ds DNA Bacteriophage Forecasted Market Size by Region (2025-2030)
2.3 Ds DNA Bacteriophage Market Dynamics
2.3.1 Ds DNA Bacteriophage Industry Trends
2.3.2 Ds DNA Bacteriophage Market Drivers
2.3.3 Ds DNA Bacteriophage Market Challenges
2.3.4 Ds DNA Bacteriophage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ds DNA Bacteriophage Players by Revenue
3.1.1 Global Top Ds DNA Bacteriophage Players by Revenue (2019-2024)
3.1.2 Global Ds DNA Bacteriophage Revenue Market Share by Players (2019-2024)
3.2 Global Ds DNA Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ds DNA Bacteriophage Revenue
3.4 Global Ds DNA Bacteriophage Market Concentration Ratio
3.4.1 Global Ds DNA Bacteriophage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ds DNA Bacteriophage Revenue in 2023
3.5 Ds DNA Bacteriophage Key Players Head office and Area Served
3.6 Key Players Ds DNA Bacteriophage Product Solution and Service
3.7 Date of Enter into Ds DNA Bacteriophage Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ds DNA Bacteriophage Breakdown Data by Type
4.1 Global Ds DNA Bacteriophage Historic Market Size by Type (2019-2024)
4.2 Global Ds DNA Bacteriophage Forecasted Market Size by Type (2025-2030)
5 Ds DNA Bacteriophage Breakdown Data by Application
5.1 Global Ds DNA Bacteriophage Historic Market Size by Application (2019-2024)
5.2 Global Ds DNA Bacteriophage Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ds DNA Bacteriophage Market Size (2019-2030)
6.2 North America Ds DNA Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ds DNA Bacteriophage Market Size by Country (2019-2024)
6.4 North America Ds DNA Bacteriophage Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ds DNA Bacteriophage Market Size (2019-2030)
7.2 Europe Ds DNA Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ds DNA Bacteriophage Market Size by Country (2019-2024)
7.4 Europe Ds DNA Bacteriophage Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ds DNA Bacteriophage Market Size (2019-2030)
8.2 Asia-Pacific Ds DNA Bacteriophage Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ds DNA Bacteriophage Market Size by Region (2019-2024)
8.4 Asia-Pacific Ds DNA Bacteriophage Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ds DNA Bacteriophage Market Size (2019-2030)
9.2 Latin America Ds DNA Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ds DNA Bacteriophage Market Size by Country (2019-2024)
9.4 Latin America Ds DNA Bacteriophage Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ds DNA Bacteriophage Market Size (2019-2030)
10.2 Middle East & Africa Ds DNA Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ds DNA Bacteriophage Market Size by Country (2019-2024)
10.4 Middle East & Africa Ds DNA Bacteriophage Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Ds DNA Bacteriophage Introduction
11.1.4 Thermo Fisher Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Agilent
11.2.1 Agilent Company Detail
11.2.2 Agilent Business Overview
11.2.3 Agilent Ds DNA Bacteriophage Introduction
11.2.4 Agilent Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.2.5 Agilent Recent Development
11.3 NPO Microgen
11.3.1 NPO Microgen Company Detail
11.3.2 NPO Microgen Business Overview
11.3.3 NPO Microgen Ds DNA Bacteriophage Introduction
11.3.4 NPO Microgen Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.3.5 NPO Microgen Recent Development
11.4 Proteon Pharmaceuticals
11.4.1 Proteon Pharmaceuticals Company Detail
11.4.2 Proteon Pharmaceuticals Business Overview
11.4.3 Proteon Pharmaceuticals Ds DNA Bacteriophage Introduction
11.4.4 Proteon Pharmaceuticals Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.4.5 Proteon Pharmaceuticals Recent Development
11.5 Phagelux
11.5.1 Phagelux Company Detail
11.5.2 Phagelux Business Overview
11.5.3 Phagelux Ds DNA Bacteriophage Introduction
11.5.4 Phagelux Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.5.5 Phagelux Recent Development
11.6 Intralytix
11.6.1 Intralytix Company Detail
11.6.2 Intralytix Business Overview
11.6.3 Intralytix Ds DNA Bacteriophage Introduction
11.6.4 Intralytix Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.6.5 Intralytix Recent Development
11.7 Micreos
11.7.1 Micreos Company Detail
11.7.2 Micreos Business Overview
11.7.3 Micreos Ds DNA Bacteriophage Introduction
11.7.4 Micreos Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.7.5 Micreos Recent Development
11.8 Eliava BioPreparations
11.8.1 Eliava BioPreparations Company Detail
11.8.2 Eliava BioPreparations Business Overview
11.8.3 Eliava BioPreparations Ds DNA Bacteriophage Introduction
11.8.4 Eliava BioPreparations Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.8.5 Eliava BioPreparations Recent Development
11.9 Locus Biosciences, Inc
11.9.1 Locus Biosciences, Inc Company Detail
11.9.2 Locus Biosciences, Inc Business Overview
11.9.3 Locus Biosciences, Inc Ds DNA Bacteriophage Introduction
11.9.4 Locus Biosciences, Inc Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.9.5 Locus Biosciences, Inc Recent Development
11.10 Pharmex Group, LLC
11.10.1 Pharmex Group, LLC Company Detail
11.10.2 Pharmex Group, LLC Business Overview
11.10.3 Pharmex Group, LLC Ds DNA Bacteriophage Introduction
11.10.4 Pharmex Group, LLC Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.10.5 Pharmex Group, LLC Recent Development
11.11 Pherecydes Pharma
11.11.1 Pherecydes Pharma Company Detail
11.11.2 Pherecydes Pharma Business Overview
11.11.3 Pherecydes Pharma Ds DNA Bacteriophage Introduction
11.11.4 Pherecydes Pharma Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.11.5 Pherecydes Pharma Recent Development
11.12 APS Biocontrol Ltd. (APS)
11.12.1 APS Biocontrol Ltd. (APS) Company Detail
11.12.2 APS Biocontrol Ltd. (APS) Business Overview
11.12.3 APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Introduction
11.12.4 APS Biocontrol Ltd. (APS) Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.12.5 APS Biocontrol Ltd. (APS) Recent Development
11.13 Qingdao Phagepharm Bio-tech
11.13.1 Qingdao Phagepharm Bio-tech Company Detail
11.13.2 Qingdao Phagepharm Bio-tech Business Overview
11.13.3 Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Introduction
11.13.4 Qingdao Phagepharm Bio-tech Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.13.5 Qingdao Phagepharm Bio-tech Recent Development
11.14 Fixed-Phage Limited
11.14.1 Fixed-Phage Limited Company Detail
11.14.2 Fixed-Phage Limited Business Overview
11.14.3 Fixed-Phage Limited Ds DNA Bacteriophage Introduction
11.14.4 Fixed-Phage Limited Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.14.5 Fixed-Phage Limited Recent Development
11.15 Zeptometrix
11.15.1 Zeptometrix Company Detail
11.15.2 Zeptometrix Business Overview
11.15.3 Zeptometrix Ds DNA Bacteriophage Introduction
11.15.4 Zeptometrix Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.15.5 Zeptometrix Recent Development
11.16 Phage International, Inc.
11.16.1 Phage International, Inc. Company Detail
11.16.2 Phage International, Inc. Business Overview
11.16.3 Phage International, Inc. Ds DNA Bacteriophage Introduction
11.16.4 Phage International, Inc. Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.16.5 Phage International, Inc. Recent Development
11.17 MicroMir
11.17.1 MicroMir Company Detail
11.17.2 MicroMir Business Overview
11.17.3 MicroMir Ds DNA Bacteriophage Introduction
11.17.4 MicroMir Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.17.5 MicroMir Recent Development
11.18 iNtODEWORLD, Inc.
11.18.1 iNtODEWORLD, Inc. Company Detail
11.18.2 iNtODEWORLD, Inc. Business Overview
11.18.3 iNtODEWORLD, Inc. Ds DNA Bacteriophage Introduction
11.18.4 iNtODEWORLD, Inc. Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.18.5 iNtODEWORLD, Inc. Recent Development
11.19 NEXTBIOTICS
11.19.1 NEXTBIOTICS Company Detail
11.19.2 NEXTBIOTICS Business Overview
11.19.3 NEXTBIOTICS Ds DNA Bacteriophage Introduction
11.19.4 NEXTBIOTICS Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.19.5 NEXTBIOTICS Recent Development
11.20 Armata Pharmaceuticals, Inc.
11.20.1 Armata Pharmaceuticals, Inc. Company Detail
11.20.2 Armata Pharmaceuticals, Inc. Business Overview
11.20.3 Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Introduction
11.20.4 Armata Pharmaceuticals, Inc. Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.20.5 Armata Pharmaceuticals, Inc. Recent Development
11.21 Innophage
11.21.1 Innophage Company Detail
11.21.2 Innophage Business Overview
11.21.3 Innophage Ds DNA Bacteriophage Introduction
11.21.4 Innophage Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.21.5 Innophage Recent Development
11.22 Adaptive Phage Therapeutics
11.22.1 Adaptive Phage Therapeutics Company Detail
11.22.2 Adaptive Phage Therapeutics Business Overview
11.22.3 Adaptive Phage Therapeutics Ds DNA Bacteriophage Introduction
11.22.4 Adaptive Phage Therapeutics Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.22.5 Adaptive Phage Therapeutics Recent Development
11.23 TechnoPhage
11.23.1 TechnoPhage Company Detail
11.23.2 TechnoPhage Business Overview
11.23.3 TechnoPhage Ds DNA Bacteriophage Introduction
11.23.4 TechnoPhage Revenue in Ds DNA Bacteriophage Business (2019-2024)
11.23.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher
Agilent
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
听
听
*If Applicable.
